ArticleCureus2025
Inflammatory Myofibroblastic Tumour of the Bladder in a Young Male: A Rare Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Inflammatory myofibroblastic tumour (IMT) of the urinary bladder is a rare mesenchymal neoplasm characterised by spindle-shaped myofibroblastic cells and an accompanying inflammatory infiltrate. Although its aetiology remains unclear, histopathological and immunohistochemical analyses are essential for diagnosis. We report the case of an 18-year-old male who presented with sudden-onset, painless gross haematuria. Initial evaluation revealed severe anaemia, necessitating blood transfusion. Renal ultrasound demonstrated a large echogenic lesion within the bladder. Cystoscopy revealed a large, polypoidal tumour on the right lateral bladder wall with active bleeding. The tumour was completely resected via transurethral resection of bladder tumour (TURBT). Histopathological examination confirmed IMT, with immunohistochemical staining positive for smooth muscle actin (SMA) and anaplastic lymphoma kinase (ALK), supporting the diagnosis. The patient remained stable postoperatively, with no recurrence at three- and six-month follow-up. Bladder IMTs are uncommon, particularly in young males, and typically present with non-specific urinary symptoms, most notably haematuria. Differentiation from other spindle cell neoplasms, including urothelial carcinoma and sarcomas, is crucial for appropriate management. Complete surgical excision is typically curative, and ongoing surveillance with periodic cystoscopy is recommended due to the potential for recurrence. IMT of the bladder is a rare but important differential diagnosis for bladder tumours in young patients presenting with haematuria. Timely diagnosis and surgical intervention can lead to favourable outcomes, underscoring the importance of clinical awareness.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.